510(k) Report

510(k) · Cleared

Recalled · Class II · 2024

Welch Allyn Diagnostic Cardiology Suite 2.X.X with Spirometry option

K191013510(k) TraditionalCleared Sep 10, 2019146-day reviewClass II21 CFR 868.1840Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Welch Allyn, Inc. · BZG Spirometer, Diagnostic

Cleared on Sep 10, 2019 as substantially equivalent to K082478 (Welch Allyn, Inc., 2009) after a 146-day review. Its family tree reaches back 3 generations to 1996. It has been recalled once.

Decided
Sep 10, 2019
Review
146 days
Class
Class II
Product code
BZG
Recalls
1
Predicates
1

Its longest line of descent runs back 3 generations to K935732 (1996). 5 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 3 generations backK935732 Cardio Perfect ST 2001Cardio Control BV · 1996
  2. 2 generations backK052158 Welch Allyn Cardioperfect Workstation Version 1.5.0 SoftwareWelch Allyn, Inc. · 2005
  3. 1 generation backK082478 Welch Allyn Cardioperfect Workstation Software (CPWS) V 1.62Welch Allyn, Inc. · 2009
  4. This deviceK191013 Welch Allyn Diagnostic Cardiology Suite 2.X.X with Spirometry optionWelch Allyn, Inc. · 2019
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K935732Cardio Perfect ST 2001Cardio Control BV1996—
−2K052158Welch Allyn Cardioperfect Workstation Version 1.5.0 SoftwareWelch Allyn, Inc.2005—
−1K082478Welch Allyn Cardioperfect Workstation Software (CPWS) V 1.62Welch Allyn, Inc.2009—
0 (this device)K191013Welch Allyn Diagnostic Cardiology Suite 2.X.X with Spirometry optionWelch Allyn, Inc.2019—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
199810
FIG. 1 — Lineage of K191013, 1996–2019Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in BZG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new BZG device

  1. #1 K251777 MESI mTABLET SPIROscore 13.0 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K082478Welch Allyn Cardioperfect Workstation Software (CPWS) V 1.62
Summary page 4
…ulation: DPS, 870.2340 Predicate Device: Welch Allyn CardioPerfect® Workstation Software™ (CPWS) 901047 CARDIOPULMONAY ECG SYSTEM (K082478) Reference Device: Welch Allyn® RScribe™ (K120865) 901127 ELECTROCARDIOGRAPH Backgro…
Welch Allyn, Inc.2009—
†K120865Rscribe ElectrocardiographMortara Instrument, Inc.20121

Also cleared against K082478: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Oct 11, 2024Class IIZ-0324-2025Software designThere is the potential for exam files being assigned duplicate Unique Identifiers (UIDs),. If the system receiving the DICOM file (e.g., Picture Archiving and Communication System (PACS)) relies solely on the UID to accept exams, this…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 2 companies; a new generation was cleared every 9.4 years on median.
  • None of the 5 ancestors has a recall.
  • 1 other device also cites its predicate K082478.

How does its category compare?

All BZG devices

BZG Spirometer, Diagnostic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · BZG

2in 2024

2007: 32008: 32009: 82010: 42011: 62012: 32013: 32014: 52015: 52016: 42017: 22018: 12019: 32020: 52021: 12022: 22023: 52024: 22026 (partial year): 1
2007high 8 (2009) · low 0 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · BZG

362in 2023

2007: 121 days median2008: 209 days median2009: 141 days median2010: 181 days median2011: 278 days median2012: 59 days median2013: 266 days median2014: 154 days median2015: 273 days median2016: 235 days median2019: 146 days median2020: 126 days median2023: 362 days median
2007high 362 (2023) · low 59 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · BZG

1in 2024

2024: 1
2007high 1 (2024) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · BZG

1in 2025

2007: 12011: 12012: 22013: 12014: 12015: 12016: 12017: 12018: 12019: 12020: 22021: 12022: 32023: 22024: 32025: 1
2007high 3 (2022) · low 0 (2008)2025

MAUDE reports naming product code BZG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007312101
2008320900
2009814100
2010418100
2011627801
201235902
2013326601
2014515401
2015527301
2016423501
20172—01
20181—01
2019314601
2020512602
20211—01
20222—03
2023536202
20242—13
20250—01
20261—0—

What is it indicated for?

The Welch Allyn® Diagnostic Cardiology Suite™ is a prescription device intended for use by physicians, other licensed health care practitioners, and trained personnel who are acting on the orders of a physician. Welch Allyn Diagnostic Cardiology Suite is intended for use in medical clinics, physician offices and hospital settings to acquire, analyze, display, transmit and print certain physiological signals identified below and provide the data for…

Read the full statement (375 words)

The Welch Allyn® Diagnostic Cardiology Suite™ is a prescription device intended for use by physicians, other licensed health care practitioners, and trained personnel who are acting on the orders of a physician. Welch Allyn Diagnostic Cardiology Suite is intended for use in medical clinics, physician offices and hospital settings to acquire, analyze, display, transmit and print certain physiological signals identified below and provide the data for consideration by a physician.

Welch Allyn Diagnostic Cardiology Suite utilizes a software platform to support 12-lead diagnostic resting ECG and diagnostic Spirometry applications and is designed to operate within the inherent capabilities of an off-the-shelf laptop or PC Windows operating system. Welch Allyn Diagnostic Cardiology Suite also provides functions related to patient data management including communication with electronic medical records systems. Welch Allyn Diagnostic Cardiology Suite Resting ECG’s are intended to be taken with the patient in the supine position and offer VERITAS™ resting ECG algorithm to generate measurements and advisory statements for review and interpretation by the physician.

Welch Allyn Diagnostic Cardiology Suite is not intended to be used as a physiological vital signs monitor, not intended to be used in a mobile medical environment (e.g. ambulance, helicopter), in magnetic resonance (MR) environments, in operating theaters, nor in conjunction with high frequency surgical equipment.

Indications for Welch Allyn Diagnostic Cardiology Suite ECG range from routine screening of cardiac health in the physician office environment to directed diagnostic differentiation in a hospital cardiology department. Welch Allyn Diagnostic Cardiology Suite ECG is indicated for patients of all ages.

Welch Allyn Diagnostic Cardiology Suite Spirometry is indicated for pulmonary function testing, providing forced expiratory flow-volume and time measurements. The device is intended to be a general assessment tool assisting the clinician in the diagnosis of pulmonary function. These devices are commonly used on patients with occupational exposure to dust or chemicals; presenting with symptoms such as chronic cough, shortness of breath and wheezing; disorders such as interstitial lung disease, bronchitis, asthma, and COPD; or other patients where the clinician determines these pulmonary function measurements are needed. Welch Allyn Diagnostic Cardiology Suite with Spirometry is indicated for adult and pediatric patients age 6 years and older and should only be used with patients able to understand the instructions for performing the test.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K191013: Welch Allyn Diagnostic Cardiology Suite 2.X.X with Spirometry option.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K191013

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026